WCG Mapping Arthritis Markers (MAM)

Medikamentensuche durch "Docking"-Simulationen (Mapping Cancer Markers, FightAIDS@home, Smash Childhood Cancer, ...)
Nachricht
Autor
Stiwi
Powerknopf-Verweigerer
Powerknopf-Verweigerer
Beiträge: 1466
Registriert: 20.05.2012 21:11

WCG Mapping Arthritis Markers (MAM)

#1 Ungelesener Beitrag von Stiwi » 21.11.2024 23:25

Es wurde ein neues Projekt angekündigt.
https://www.worldcommunitygrid.org/newsletters

Parallel arbeiten sie massiv daran die Probleme die ARP verursacht in den Griff zu bekommen
https://www.cs.toronto.edu/~juris/jlab/wcg.html unter operational Status
Bild
Bild

Benutzeravatar
Michael H.W. Weber
Vereinsvorstand
Vereinsvorstand
Beiträge: 22668
Registriert: 07.01.2002 01:00
Wohnort: Marpurk
Kontaktdaten:

Re: WCG Mapping Arthritis Markers (MAM)

#2 Ungelesener Beitrag von Michael H.W. Weber » 23.11.2024 15:00

Cool.

Michael.
Fördern, kooperieren und konstruieren statt fordern, konkurrieren und konsumieren.

Bild Bild

Stiwi
Powerknopf-Verweigerer
Powerknopf-Verweigerer
Beiträge: 1466
Registriert: 20.05.2012 21:11

Re: WCG Mapping Arthritis Markers (MAM)

#3 Ungelesener Beitrag von Stiwi » 21.12.2024 03:47

Das Team hinter WCG scheint während der Downtime fleißig zu sein:
December 20, 2024
  • We have begun testing the Mapping Arthritis Markers (MAM1) prototype based on the current MCM1 code. We expect to launch the beta version of the application shortly after we are back online on the 3rd of January. We will provide a firm launch date once we are back online. The GPU version of the project may take some additional time to develop and test.
  • We have been reviewing the MCM1 application code and considering alternative upgrade paths for MCM1 and related projects to enable GPU compute for gene signature search in general. We have decided to work towards replacing the SvmLightLib dependency and other related sections of the code with more modern, but still self-contained dependencies that will provide the opportunity to select CPU vs. GPU backend depending on user preferences and device capability. This should also enable us to take advantage of modern instruction sets and possibly other architectures in the future.
  • We will be able to publish a preliminary benchmark of the old vs. new application code, comparing across a selection of hardware that WCG staff have at home. We expect performance improvements and better memory utilization for the new version of the MCM1 and by extension initial implementation of the MAM1 project.
  • In light of the merger of this pull request (introducing "BUDA" to the latest BOINC server releases), we find a strong motivation to upgrade our BOINC server version to track BOINC upstream as nearly every bioinformatics application we have experience running in an HPC environment we could run on the grid, if only we could run containers. We have considered multiple different strategies to accomplish this migration in the past, and now that we have occasion to test existing and new applications with the newest BOINC server version during this downtime offsite, we will put together a roadmap after the launch of MAM1 and upgrade BOINC server to use BUDA/containers going forward.
Bild
Bild

Antworten

Zurück zu „Medikamentensuche“